Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. (Q35858051)
Jump to navigation
Jump to search
scientific article published on 26 March 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. |
scientific article published on 26 March 2012 |
Statements
Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models (English)
Cynthia X Ma
Shirong Cai
Shunqiang Li
Christine E Ryan
Zhanfang Guo
W Timothy Schaiff
Li Lin
Jeremy Hoog
Rebecca L Aft
Matthew J Ellis
Helen Piwnica-Worms
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference